The Regional Health Contracting Office-Central, JBSA - Fort Sam Houston,
Texas intends to award a Firm-Fixed-Price sole source contract to Biocompatible Inc. under the authority of Federal Acquisition Regulation (FAR) 13.501(a)(1)(ii), sole source, for the Biocompatibles Inc. a FDA approved TheraSphere doses product for use in radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable hepatocellular carcinoma (HCC) who can have placement of appropriately positioned hepatic arterial catheters. These supplies are needed to treat liver cancer patients in the Regional Health Command Central (RHC-C).

The applicable NAICS code for this requirement is 325412, Pharmaceutical Preparation Manufacturing. The Small Business Size Standard is 1,250 employees. Award will be made on or after 22 June 2018.

The solicitation number is W81K0018Q0072, and is generated for the purposes of posting this notice. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. All responses received, to include capability statements, by 21 June 2018-11:00AM CST of the posting of this notice will be considered by the Government. A determination by the Government not to compete the interim purchase order based upon responses to this notice is solely within the discretion of the Government. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature.